Essel’s quarterly net profit up 44.5% at Rs 42.9 crore

Essel Propack, a global leader in laminated plastic tubes catering to the FMCG and pharma segments, on 21 January 2016 announced its financial results for the quarter ended 31 December 2015.

01 Feb 2016 | By Dibyajyoti Sarma

The company had divested its flexible packaging business in July 2015.

On a comparable basis, the company’s consolidated quarterly net profit, excluding divested business, was up 44.5% at Rs 42.9 crore as against Rs 29.7 crore in the corresponding quarter of last year.

On a comparable basis, the company’s consolidated quarterly revenue, excluding divested business, was up 1.2% at Rs 513.4 crore as against Rs 507.4 crore in the corresponding quarter of last year.

On a comparable basis, the company’s consolidated nine-month net profit, excluding divested business, was up 36.3% at Rs 127.8 crore as against Rs 93.8 crore in the corresponding 9MFY15.

On a comparable basis, the company’s consolidated nine-month revenue, excluding divested business, was up 3.1% at Rs 1,573.3 crore as against Rs 1,525.6 crore in the corresponding 9MFY15.

Commenting on the results, Ashok Goel, vice-chairman and managing director, Essel Propack, said, “Europe and Americas are on track. Margins have been helped by stable RM prices and operational efficiencies. We believe, continued growth in Europe and Latin America and demand revival in India will drive our topline growth to 15% CAGR in the coming quarters.”

Essel Propack, part of the USD 2.4 billion Essel Group, with FY15 turnover of over USD 380 million, is the largest specialty packaging global company, manufacturing laminated plastic tubes catering to the FMCG and pharma space. Employing over 2,700 people representing 25 different nationalities, Essel Propack functions through 21 state-of-the-art facilities and in 11 countries, selling more than six billion tubes.

BUSINESS HIGHLIGHTS FOR THE QUARTER
  • Europe expansion is on track with strong revenue growth.
     
  • EAP margin improved and non-oral care share increase.
     
  • Americas margin improve due to better efficiencies.
     
  • AMESA revenue performance is impacted by sluggish economy in India and pass thru of RM price reduction.
     
  • Net debt reduced by Rs 241 crore year on year.

 

COMPARISON OF Q3FY16 and Q3FY15 CONSOLIDATED RESULTS
  • Net profit for the quarter at Rs 42.9 crore as against Rs 30.4 crore last year.
  • Income from operations for the quarter at Rs 513.4 crore as against Rs 567.4 crore last year.
     
  • Revenue for the continuing business grew by 5.2% on underlying basis compared to same quarter previous year, adjusted for RM price reduction pass thru.
     
  • Comparable basis continuing business net profit at Rs 42.9 crore, up by 44.5%.
     
  • EBITDA margin at 20.0% as against 17.5% for continuing business.
     
  • EPS for the quarter ended December 31, 2015 was Rs 2.73 as against Rs 1.94 on Rs. 2 face value per share.